Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ideaya Biosciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Ideaya Biosciences

Ideaya Biosciences

Public

IDEAYA Biosciences, a California-based biotech firm, develops oncology-focused drugs for cancer treatment.

HQ
South San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

IDEAYA Biosciences, founded in South San Francisco, California, is a clinical-stage precision medicine oncology company. The company's core mission is to improve lives through transformative precision medicines. IDEAYA focuses on developing targeted therapeutics for cancer treatment, specifically for patient populations selected using molecular diagnostics. Their primary area of expertise is synthetic lethality, an emerging class of precision medicine targets.

Notable affiliated people include prominent scientists and industry leaders who have significantly contributed to the field of oncology. IDEAYA has garnered substantial investment from leading venture capital firms and strategic partners in the healthcare sector. Key achievements include advancing several first-in-class and best-in-class therapeutics into clinical trials, demonstrating significant potential in cancer treatment. The company's impact is marked by its innovative approach to precision medicine, aiming to provide more effective and personalized cancer therapies.

Ideaya Biosciences - Similar Companies

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Sutro Biopharma logo

Sutro Biopharma

sutrobio.com

Akoya Biosciences logo

Akoya Biosciences

akoyabio.com

Iyuda Therapeutics logo

Iyuda Therapeutics

Revolution Medicines logo

Revolution Medicines

revmed.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

Massive Bio logo

Massive Bio

massivebio.com

Whitehawk Therapeutics logo

Whitehawk Therapeutics

aadibio.com

Twist Bioscience logo

Twist Bioscience

HI-Bio logo

HI-Bio

hibio.com

Precision BioSciences logo

Precision BioSciences

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

SunnyBay BioTech logo

SunnyBay BioTech

Ideaya Biosciences - Quick Facts

Who are Ideaya Biosciences' competitors?

Companies similar to Ideaya Biosciences include Synnovation Therapeutics, Immune-Onc Therapeutics, Sutro Biopharma and Akoya Biosciences.

When was Ideaya Biosciences founded?

Ideaya Biosciences was founded in 2015.

Where is Ideaya Biosciences' headquarters located?

Ideaya Biosciences' headquarters is located in South San Francisco, CA, US.

When was Ideaya Biosciences' last funding round?

Ideaya Biosciences' most recent funding round was for $125M (USD) in October 2023.

How much has Ideaya Biosciences raised to-date?

As of Oct 24, 2023, Ideaya Biosciences has raised a total of $431.1M (USD).

How many employees does Ideaya Biosciences have?

Ideaya Biosciences has 103 employees as of Feb 6, 2024.

Ideaya Biosciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Oncology Drugs
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 474268251
  • secCik: 0001676725
  • ticker: IDYA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research